These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2964020)

  • 1. [Value of triiodothyroacetic acid as suppressive treatment of the thyrotropin secretion in thyroid pathology].
    Jaffiol C; Baldet L; Papachristou C; Bringer J
    Presse Med; 1988 Jan; 17(2):57-60. PubMed ID: 2964020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
    Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
    Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial nonneoplastic inappropriate thyrotropin secretion].
    Langer HJ; Leicht E; Koch B; Weinheimer B; Berberich R; Strohfeldt P; Weinges KF
    Dtsch Med Wochenschr; 1990 May; 115(21):813-6. PubMed ID: 2340804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
    Mechelany C; Schlumberger M; Challeton C; Comoy E; Parmentier C
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
    J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).
    Beck-Peccoz P; Piscitelli G; Cattaneo MG; Faglia G
    J Endocrinol Invest; 1983 Jun; 6(3):217-23. PubMed ID: 6619530
    [No Abstract]   [Full Text] [Related]  

  • 7. Triac (3,5,3'-triiodothyroacetic acid) partially inhibits the thyrotropin response to synthetic thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients.
    Medeiros-Neto G; Kallas WG; Knobel M; Cavaliere H; Mattar E
    J Clin Endocrinol Metab; 1980 Feb; 50(2):223-5. PubMed ID: 6766460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperthyroidism caused by inadequate TSH secretion].
    Zass R; Steindor U; Wendel U
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
    Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K
    Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thyroid hormone analogue, triiodothyroacetic acid, corrects corticosteroid-downregulated collagen synthesis.
    Yazdanparast P; Carlsson B; Oikarinen A; Risteli J; Faergemann J
    Thyroid; 2004 May; 14(5):345-53. PubMed ID: 15186610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5,3'-Triiodothyroacetic acid (TRIAC) effects on pituitary thyroid regulation and on peripheral tissue parameters.
    Lind P; Langsteger W; Költringer P; Eber O
    Nuklearmedizin; 1989 Dec; 28(6):217-20. PubMed ID: 2608444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells.
    Everts ME; Visser TJ; Moerings EP; Docter R; van Toor H; Tempelaars AM; de Jong M; Krenning EP; Hennemann G
    Endocrinology; 1994 Dec; 135(6):2700-7. PubMed ID: 7988460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
    Bracco D; Morin O; Schutz Y; Liang H; Jéquier E; Burger AG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):221-8. PubMed ID: 8325946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
    Darendeliler F; Baş F
    J Pediatr Endocrinol Metab; 1997; 10(5):535-8. PubMed ID: 9401912
    [No Abstract]   [Full Text] [Related]  

  • 16. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
    Takeda T; Suzuki S; Liu RT; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
    Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P
    Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.
    Aguilar Diosdado M; Escobar-Jimenez L; Fernandez Soto ML; Garcia Curiel A; Escobar-Jimenez F
    J Endocrinol Invest; 1991 Sep; 14(8):663-8. PubMed ID: 1774450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermogenic effect of triiodothyroacetic acid at low doses in rat adipose tissue without adverse side effects in the thyroid axis.
    Medina-Gomez G; Calvo RM; Obregon MJ
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E688-97. PubMed ID: 18285526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triac reduces serum TSH without decreasing alpha and beta TSH messenger RNAs.
    Mirell CJ; Yanagisawa M; Hershman JM
    Horm Metab Res; 1989 Mar; 21(3):123-6. PubMed ID: 2744717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.